Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial.

MLA

Ying Zhou, et al. “Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis Progression and Epicardial Adipose Tissue Volume Reduction in Patients with Coronary Atherosclerosis Detected by Coronary Computed Tomography Angiography: Study Protocol for a Randomized Controlled Trial.” Trials, vol. 17, Jan. 2016, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13063-015-1097-z.

APA

Ying Zhou, Feng Tian, Jing Wang, Jun-Jie Yang, Tao Zhang, Jing Jing, Yun-Dai Chen, Zhou, Y., Tian, F., Wang, J., Yang, J.-J., Zhang, T., Jing, J., & Chen, Y.-D. (2016). Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial. Trials, 17, 1–8. https://doi.org/10.1186/s13063-015-1097-z

Chicago

Ying Zhou, Feng Tian, Jing Wang, Jun-Jie Yang, Tao Zhang, Jing Jing, Yun-Dai Chen, et al. 2016. “Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis Progression and Epicardial Adipose Tissue Volume Reduction in Patients with Coronary Atherosclerosis Detected by Coronary Computed Tomography Angiography: Study Protocol for a Randomized Controlled Trial.” Trials 17 (January): 1–8. doi:10.1186/s13063-015-1097-z.